10967/276 - QDB Compounds

QsarDB Repository

Zukic, S.; Ivanova, L.; Zusinaite, E.; Merits, A.; Maran, U. Discovery of a Novel Phthalazine-Based VEGFR-2 Inhibitor by Machine Learning Analysis of Diverse Chemical Space with Favorable Pharmacophores and Its Evaluation in Glioblastoma Cell Lines. Results in Chemistry, Under revision

Compound

ID:136
Name:Compound 136
Description:Original numeration in publication: 6a
Labels:Training_set, Phthalazines
CAS:
InChi Code:InChI=1S/C28H21N5O/c34-28(33-29-19-20-9-3-1-4-10-20)22-15-17-23(18-16-22)30-27-25-14-8-7-13-24(25)26(31-32-27)21-11-5-2-6-12-21/h1-19H,(H,30,32)(H,33,34)/b29-19+

Properties

pIC50: Negative logarithm of half-maximal inhibitory concentration [-log(uM)]

ValueSource or prediction
6.15

El-Adl, K.; Ibrahim, M. K.; Khedr, F. a. A., H. S.; Eissa, I. H. Design, synthesis, docking, and anticancer evaluations of phthalazines as VEGFR-2 inhibitors. Arch. Pharm. (Weinheim) 2022, 355, e2100278. https://doi.org/10.1002/ardp.202100278

6.25541

Eq1: VEGFR-2 inhibition (Data used to train model)